RavenQuest BioMed To Lose Final Health Canada License

It seems that its all over for RavenQuest BioMed (CSE: RQB) as a licensed cannabis grower. The company issued a late night news release Monday, indicating that due to not having access to the Markham, Ontario facility Health Canada would be revoking the license.

The news of the license revocation follows the news last month that the company had lost its license at its Edmonton-based Alberta Green Biotech facility also due to losing access. The loss of access was the result of RavenQuest failing to pay its lease on the facility, which ultimately resulted in the landlord acquiring a court order to seize assets to cover debts owed.

The Markham facility has long been suspected of not cultivating product while the company has continued to say otherwise. The Deep Dive provided a special report back in early February, providing evidence that cultivation was likely slowed at the facility due to apparent inactivity at the site. Neighbours to the facility had indicated that the smell of cannabis used to permeate the facility but it had not been smelt for “some time.”

The company did not provide a specific timeline for the revocation of it’s Health Canada license, however it’s anticipated to be filed this Friday with the agencies weekly license update.

RavenQuest BioMed last traded at $0.01 on the CSE.


Information for this briefing was found via Sedar and RavenQuest Biomed. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

4 Responses

Leave a Reply

Video Articles

Endeavour Mining Q1 Earnings: Cash Flow Is King

G Mining Oko West Feasibility: Move Fast, Break.. Nothing?

New Gold Q1 Earnings: What’s Behind The Market’s Surprising Reaction?

Recommended

First Majestic Posts Record Cash Flows In Q1 As Production Costs Fall

Brazil Potash Secures Funding In Support Of US$2.5 Billion Autozales Project

Related News

RavenQuest Sued by RotoGro for Patent Infringement

RavenQuest BioMed (CSE: RQB) has found itself in some hot water. Roto Gro international (ASX:...

Wednesday, November 6, 2019, 01:56:09 PM

RavenQuest BioMed: The Next Bridgemark Group Target?

It seems that the now infamous Bridgemark Group might be getting the gang back together...

Tuesday, February 11, 2020, 01:06:30 PM

Will RavenQuest Biomed Survive Another Six Months?

RavenQuest Biomed Inc (CSE: RQB) released its third quarter financials last night, posting revenues of...

Tuesday, October 1, 2019, 08:00:40 AM

Bonify Holdings Reinstated: Is There Now Hope For Canntrust Holdings?

There might be hope for Canntrust Holdings (TSX: TRST) (NYSE: CTST) and its shareholders after...

Wednesday, October 23, 2019, 06:03:04 PM

RavenQuest Biomed’s Financials Reveal Key Issues

RavenQuest Biomed (CSE: RQB) put out its latest financials after the close on Friday, recognizing...

Tuesday, July 2, 2019, 07:00:26 AM